Apellis adds $35M to IPO cap, sets share price target

The local biopharmaceutical company increased its IPO cap by a double-digit percentage.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.